← back to search

Sihua Liu

Medical Plus · CZ
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Circular RNAs in diseases, MicroRNA in disease regulation, Viral Infections and Vectors, and Mosquito-borne diseases and control.
h-index
16
citations
848
works
72
NIH funding
primary concept
email

Recent publications

The features of male breast cancer in China: A real-world study
The Breast 2024cited by 9position: middledoi
Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4
Cancer Cell International 2022cited by 56position: middledoi
Identification of potential circular RNA biomarkers in lung adenocarcinoma: A bioinformatics analysis and retrospective clinical study
Oncology Letters 2022cited by 11position: middledoi
Activation of circ_0072088/<scp>miR</scp>‐1261/<scp>PIK3CA</scp> pathway accelerates lung adenocarcinoma progression
Thoracic Cancer 2022cited by 9position: middledoi
ZEB1 represses biogenesis of circ-DOCK5 to facilitate metastasis in esophageal squamous cell carcinoma via a positive feedback loop with TGF-β
Cancer Letters 2021cited by 47position: middledoi
Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis
Scientific Reports 2021cited by 16position: middledoi
ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway
Molecular Therapy — Nucleic Acids 2020cited by 51position: middledoi
The emerging prospects of circular RNA in tumor immunity
Annals of Translational Medicine 2020cited by 9position: middledoi
The emerging prospects of circular RNA in tumor immunity
Annals of Translational Medicine 2020cited by 3position: middledoi
Circular RNA ciRS‐7 inhibits autophagy of ESCC cells by functioning as miR‐1299 sponge to target EGFR signaling
Journal of Cellular Biochemistry 2019cited by 66position: middledoi
Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs
Molecular Cancer Research 2018cited by 100position: middledoi
Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins
Cell Death and Disease 2018cited by 22position: middledoi
Effect of AR antagonist combined with PARP1 inhibitor on sporadic triple-negative breast cancer bearing AR expression and methylation-mediated BRCA1 dysfunction
Biomedicine & Pharmacotherapy 2018cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Meixiang Sang · Shanghai University of Electric Power12 papers (2018–2022)Lingjiao Meng · Hebei Medical University10 papers (2018–2022)Fei Liu · Hebei Medical University6 papers (2018–2022)Lina Gu · Hebei Medical University6 papers (2018–2022)Ping’an Ding · Hebei Medical University5 papers (2018–2020)Sheng Chang · Kunming University of Science and Technology4 papers (2018–2019)Yingchao Ju · Hebei Medical University4 papers (2018–2021)Ziyi Li · Guangxi University4 papers (2020–2022)Yishui Lian · Fourth Hospital of Hebei Medical University3 papers (2018–2018)Cuizhi Geng · Hebei Medical University3 papers (2018–2020)Feng Cao · Anhui Medical University2 papers (2022–2022)Xiaochong Zhang · Hebei Medical University2 papers (2018–2021)Lingjiao Meng · Hebei Medical University2 papers (2018–2020)Meijie Sang · Hebei University of Chinese Medicine2 papers (2018–2020)Yang Zheng · Hebei Medical University2 papers (2021–2022)Baoen Shan · Hebei Medical University2 papers (2020–2020)Baoen Shan · Hebei Medical University2 papers (2022–2022)Shuguang Ren · Hebei Medical University2 papers (2021–2022)Yonggang Zhu · Ningbo University2 papers (2021–2022)Cuicui Ma · Sichuan University1 papers (2018–2018)